Compare GWRE & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GWRE | BAX |
|---|---|---|
| Founded | 2001 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 10.2B |
| IPO Year | 2011 | 1994 |
| Metric | GWRE | BAX |
|---|---|---|
| Price | $144.42 | $15.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 9 |
| Target Price | ★ $251.31 | $22.13 |
| AVG Volume (30 Days) | 1.5M | ★ 8.5M |
| Earning Date | 03-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 1257.14 | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | $719,514,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $22.17 | $1.90 |
| Revenue Next Year | $15.79 | $2.22 |
| P/E Ratio | $142.76 | ★ N/A |
| Revenue Growth | ★ 8.84 | 5.72 |
| 52 Week Low | $120.37 | $16.08 |
| 52 Week High | $272.60 | $34.52 |
| Indicator | GWRE | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 41.18 | 33.16 |
| Support Level | $121.13 | N/A |
| Resistance Level | $164.73 | $18.89 |
| Average True Range (ATR) | 6.21 | 0.75 |
| MACD | -1.58 | -0.05 |
| Stochastic Oscillator | 6.27 | 4.28 |
Guidewire Software provides cloud-based software solutions for property and casualty insurers. The flagship product, InsuranceSuite is a system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a midmarket offering, as well as a variety of other add-on applications and services.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.